Enterprise Products Partners L.P

Bye Bye Jay Time for Another Chair Insider Buying Week 3-24-23

by

We are deep in the darkness, the earnings blackout period in which corporate insiders are restricted from buying their own shares. It’s a perfect time for short sellers to prey on the frazzled nerves of investors that just experienced their first bank run since the Great Financial Recession of 2008. This time the run wasn’t caused by Wall Street and banks that sold liars loans to uncreditworthy customers but instead by the monetary policy of the Federal Reserve itself. Jay Powell left interest rates at zero far too long and raised them far too fast. He failed at running the … Read more

The Fed Gives a White XMAS to Seniors Noteworthy Insider Buys 12-23-22

by

After years, decades even of financial repression, investors are able to earn something from their risk-free savings. It could not have come at a better time for the nation’s seniors. According to the  2022 U.S. Census Bureau, more than 56 million adults ages 65 and older live in the United States, accounting for about 16.9% of the nation’s population. It’s time for them to step down off the roller coaster ride of the equity markets.  One of the cardinal rules of financial planning is that you get more risk-averse as you age. Now you can actually earn a return of … Read more

Insider Buying Week 8-5-22 CARVANA NIRVANA

by

  Curious how well insiders are doing with their buys? The Insider Report hit the ball out of the park Friday, August 5th. We hope you were in the stands with us to watch Carvana CVNA soar out of the stadium, up 40%. We have blogged about it several times in the Insiders Report. Numerous short sellers were saying that CVNA was going to go bust, and it reportedly had a short ratio of 40%, one of the largest out there. That means 40% of the holders of Carvana were betting it would go down, not up. Today they felt a … Read more

‘t In Yet

by

  Curious how well insiders are doing with their buys? Scroll the significant buys of the last year.  Last week was a predictable short-covering rally in the most savaged part of the market, high flying cloud stocks and a smattering of nonprofitable tech players. NASDAQ stocks shellacked the most typically and predictably bounced back  10-15%. But don’t kid yourself. This isn’t the real deal, at least not for most of the bag holders. Every market correction for the last 20 years or as long as we have data for ends and only ends with a tsunami of insider buying. Whether … Read more

Insider Buying week 11-19-21- Insiders are Stepping up

by

Curious how well insiders are doing with their buys? Click on this link or image above to scroll the significant buys of the last year. This report is going to be delayed due to a funeral I had to attend for my dear first cousin’s, husband, who passed away at 75years of age. It brought me back to Savannah, my hometown, on the marsh and waterways of Skidaway Island. I will get to the opinion pieces as I write the Insiders Report for myself. It’s my way of processing insider buying.  And there was a lot of it, this time … Read more

Two High Conviction Insider Buys $EVRG and $EPD- Week 9-24-21

by

For trade, details click on this link to the trades.    Name: Andrews Kirkland B Position: CFO Transaction Date: 2021-09-23  Shares Bought: 7,875 Average Price Paid: $63.67 Cost: $501,392 Name: Campbell David A Position: CEO Transaction Date: 2021-09-23  Shares Bought: 7,870 Average Price Paid: $63.66 Cost: $499,699 Company: Evergy Inc. (EVRG) Evergy is an American investor-owned utility (IOU) with publicly traded stock headquarters in Topeka, Kansas, and in Kansas City, Missouri. The company was formed from a merger of Westar Energy of Topeka and Great Plains Energy of Kansas City, Missouri, the parent company of Kansas City Power & Light. … Read more

The Bold, the Inexplicable and the Good Soldiers- Insider Buying Week 9-17-21

by

For trade, details click on this link to the trades.  There were quite a few buys last week and it took me longer than usual to update it. Also, I will provide a brief recap of the conversation I had with the Chief Medical Officer, Alexander A. Zukiwski at Casi Pharmaceuticals. Casi is a U.S. NASDAQ-listed biotech selling exclusively to the increasingly affluent Chinese middle class.  CASI is a penny stock that will turn into $dollars if things pan out the way I think. They have one approved revenue-producing product with an exciting pipeline. There is a high probability they … Read more